Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -14.09%15.07M | 117.00%8.46M | 288.19%4.72M | -9.30%59.65M | 128.09%41.18M | 4.78%17.55M | -62.27%3.9M | -112.27%-2.51M | -31.66%65.77M | 6.17%18.06M |
| Net income from continuing operations | 4,647.10%7.36M | 5.38%12.55M | 98.00%-139K | 979.45%43.61M | 256.77%38.5M | -98.67%155K | 94.81%11.91M | -828.51%-6.95M | -112.26%-4.96M | -445.77%-24.56M |
| Operating gains losses | 161.81%688K | 48.29%-2.38M | -123.98%-3.26M | 119.42%15.54M | 318.15%7.31M | -284.58%-1.11M | -336.45%-4.6M | 336.47%13.6M | 199.08%7.08M | 274.89%1.75M |
| Depreciation and amortization | -16.11%4.64M | -10.87%2.88M | -25.18%3.37M | 0.69%17.34M | 1.32%4.07M | -9.27%5.53M | 10.66%3.23M | -0.11%4.51M | -32.23%17.22M | -39.12%4.02M |
| Asset impairment expenditure | --472K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | -52.72%339K | 124.39%80K | -22.22%77K | -52.43%685K | 219.39%197K | 26.46%717K | -178.10%-328K | -83.98%99K | -27.16%1.44M | -135.79%-165K |
| Deferred tax | 1.13%6.08M | 3.83%5.97M | 125.24%5.21M | -92.22%2.28M | -168.96%-11.8M | 118.69%6.01M | 10.54%5.75M | -44.97%2.31M | 21.59%29.27M | 532.34%17.11M |
| Other non cashItems | 58.07%607K | 180.33%513K | 63.06%587K | -1,169.74%-17.39M | -2,270.76%-17.52M | 159.08%384K | -77.95%183K | -43.66%360K | -49.06%1.63M | -38.40%807K |
| Change In working capital | -187.30%-5.11M | 8.94%-11.15M | 93.10%-1.13M | -117.18%-2.42M | 6.97%20.43M | 236.21%5.86M | -72.61%-12.24M | -357.57%-16.43M | 69.73%14.08M | 280.23%19.1M |
| -Change in receivables | -3,965.66%-10.77M | -234.14%-5.39M | 318.52%7.19M | 85.65%-761K | -115.99%-599K | 96.55%-265K | 82.00%-1.61M | -77.40%1.72M | -3,611.26%-5.3M | 318.90%3.75M |
| -Change in inventory | -45.71%1.8M | 60.86%-2.31M | -399.19%-1.84M | 85.52%-1.35M | 674.07%627K | 1,734.98%3.32M | -4.01%-5.91M | 117.54%615K | -22.44%-9.31M | 108.29%81K |
| -Change in payables and accrued expense | 905.85%1.65M | 27.07%-3.44M | 65.47%-6.48M | -101.50%-310K | -92.56%1.57M | -1,105.88%-205K | -162.40%-4.72M | -920.51%-18.77M | 31.40%20.7M | 70.54%21.09M |
| -Change in other working capital | -26.63%2.21M | ---- | ---- | ---- | ---- | -16.37%3.01M | ---- | ---- | --8M | ---5.82M |
| Cash from discontinued investing activities | 0 | 0 | 0 | -38.87%-3.34M | -413.83%-1.45M | 113.40%108K | -49.30%-1.18M | -769K | -2.41M | -282K |
| Operating cash flow | -14.62%15.07M | 210.61%8.46M | 244.00%4.72M | -11.14%56.3M | 123.56%39.74M | 10.76%17.65M | -71.47%2.72M | -116.04%-3.28M | -34.16%63.36M | 4.51%17.77M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -12.71%-29.11M | -20.14%-21.02M | -18.36%-22.18M | 18.49%-94.29M | 10.19%-32.23M | -9.76%-25.83M | 29.76%-17.5M | 40.26%-18.74M | 7.77%-115.68M | 9.75%-35.89M |
| Capital expenditure reported | ---- | ---- | ---- | ---- | ---- | ---- | 34.11%-14.83M | ---- | ---- | ---- |
| Net PPE purchase and sale | ---- | ---- | -18.36%-22.18M | 17.87%-95.01M | 18.49%-88.84M | 46.15%-1.74M | -10.88%-2.67M | -1,700.00%-18.74M | -509.11%-115.68M | -1,004.79%-109M |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -7.69%-14K | ---- | ---- |
| Net business purchase and sale | ---- | ---- | ---- | --718K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net investment purchase and sale | --320K | --68K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other investing changes | -13.95%-29.43M | -20.53%-21.09M | ---- | ---- | ---- | -27.25%-25.83M | ---17.5M | 43.98%-16.98M | ---- | ---- |
| Cash from discontinued investing activities | 0 | 0 | 0 | 47.32%-59K | 0 | 27.78%-26K | -72.73%-19K | -14K | -112K | -76K |
| Investing cash flow | -12.59%-29.11M | -20.01%-21.02M | -18.27%-22.18M | 18.52%-94.35M | 10.38%-32.23M | -9.70%-25.86M | 29.72%-17.52M | 40.21%-18.75M | 7.68%-115.79M | 9.55%-35.96M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -3.28%9.37M | -33.01%16.46M | -35.70%13.19M | 19.43%47.77M | -152.63%-7.87M | 551.05%9.68M | 117.02%24.57M | 29.26%20.51M | 37.27%40M | 7.32%14.96M |
| Net issuance payments of debt | -104.35%-634K | -101.28%-315K | -63.31%14.53M | 34.13%78.41M | -102.23%-333K | 845.50%14.57M | 117.02%24.57M | 16.04%39.61M | 99.64%58.46M | 265.13%14.96M |
| Net other financing activities | 304.79%10M | --16.77M | 92.95%-1.35M | -65.98%-30.64M | ---7.54M | -2,430.05%-4.88M | ---- | -4.56%-19.1M | ---18.46M | --0 |
| Cash from discontinued financing activities | 0 | 0 | 96.15%-13K | -1.46M | 1.46M | -338K | ||||
| Financing cash flow | -3.28%9.37M | -28.79%16.46M | -39.96%13.19M | 20.41%47.76M | -153.94%-7.89M | 551.05%9.68M | 104.16%23.11M | 38.44%21.96M | 36.11%39.66M | 4.90%14.62M |
| Net cash flow | ||||||||||
| Beginning cash position | 3.36%22.73M | 41.75%18.68M | 70.86%22.79M | -49.52%13.34M | 40.24%23.62M | -17.50%22M | -57.76%13.18M | -49.52%13.34M | -2.20%26.42M | -51.66%16.84M |
| Current changes in cash | -415.25%-4.67M | -53.14%3.9M | -6,478.46%-4.28M | 175.98%9.71M | 89.32%-381K | 115.16%1.48M | 305.33%8.32M | -101.32%-65K | -25,973.47%-12.78M | 59.55%-3.57M |
| Effect of exchange rate changes | -128.57%-40K | 98.72%155K | 273.96%167K | 16.07%-256K | -709.68%-378K | 425.58%140K | 116.32%78K | 35.14%-96K | 43.93%-305K | -84.22%62K |
| Cash adjustments other than cash changes | ---- | ---- | ---- | ---- | ---- | --71K | --348K | ---- | ---- | ---- |
| End cash Position | -23.69%18.02M | 5.36%22.73M | 41.77%18.68M | 70.86%22.79M | 70.86%22.79M | 40.24%23.62M | -19.07%21.58M | -57.76%13.18M | -49.52%13.34M | -49.52%13.34M |
| Free cash from | -14.62%15.07M | 210.61%8.46M | 20.67%-17.46M | 26.02%-38.71M | 39.41%-55.28M | 38.97%17.65M | 117.73%2.72M | -213.64%-22.01M | -167.82%-52.33M | -1,378.02%-91.23M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.